Living with Multiple Sclerosis (MS) isn't easy—especially when you're raising two kids and studying toward a degree in social work. That's exactly what Karen was facing in 1995.
But she couldn't have anticipated the sudden, frequent, uncontrollable episodes of exaggerated crying and laughing that impacted her life. Karen was committed to finding an answer. Her journey toward a PBA diagnosis and treatment was a long one, but she never gave up.
Karen, Patient with Multiple Sclerosis and PBA, taking NUEDEXTA
“NUEDEXTA really has a significant impact. I feel better not having to worry as much about having an unpredictable episode in public.”
Living with MS
Through the years, while working, studying, raising her children, and managing her MS symptoms, Karen also had to cope with those uncontrollable crying and laughing episodes. “I would hide when I used to have a crying or laughing episode in front of my family or coworkers—I would go to the bathroom and wait it out,” Karen says. “I was very, very embarrassed!”
Finally, Karen found a name for the symptoms in an MS forum: Pseudobulbar Affect, also known as PBA—sudden, frequent, uncontrollable episodes of crying and/or laughing that are exaggerated and/or don’t match how the person feels. And in 2009, she heard about a clinical trial for a drug being studied for the treatment of PBA.
“I wanted to feel comfortable and to stop worrying about the crying and laughing episodes. I had to do something,” says Karen.
"I don’t want to go back to worrying so often about suddenly having a PBA episode. I'm grateful to be taking NUEDEXTA as my treatment for PBA.”
Seeing results with NUEDEXTA
The treatment in that trial became NUEDEXTA. Karen’s been taking NUEDEXTA since it became available for prescription in 2010 to reduce her PBA episodes, under her doctor’s supervision. Reducing her PBA episodes has allowed her to focus on other aspects of her life.
Karen is a real patient and has been compensated.